Fatal MDMA intoxication (multiple letter) [6]

Lancet

Volumn 353, Issue 9152, 1999, Pages 593-594

  De la Torre, R ^a   Ortuno, J ^a   Mas, M ^a   Farre, M ^a   Segura, J ^a   Schwab, M ^a   Seyringer, E ^a   Brauer, R B ^a   Hellinger, A ^a   Griese, E U ^a  

^a INST MUNIC D INVESTIGACIO MEDICA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; RITONAVIR; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; CYTOCHROME P450 2D6; PSYCHEDELIC AGENT;

ADOLESCENT; CASE REPORT; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG INTOXICATION; FEMALE; HUMAN; LETTER; MALE; NORMAL HUMAN; PRIORITY JOURNAL; DRUG INTERACTION; METABOLISM; NOTE;

ANTI-HIV AGENTS; CYTOCHROME P-450 CYP2D6; DRUG INTERACTIONS; HALLUCINOGENS; HUMANS; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; RITONAVIR;

EID: 85045781242     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)75653-1     Document Type: Letter

References (5)

1. JA Henry IR Hill Fatal interaction between ritonavir and MDMA Lancet 352 1998 1751 1752
2. GT Tucker MS Lennard SW Ellis The demethylenation of methylenedioxyamphetamine (“ecstasy”) by debrisoquine hydroxylase (CYP2D6) Biochem Pharmacol 47 1994 1151 1156
3. A Hsu R Granneman RJ Bertz Ritonavir Clinical pharmacokinetics and interactions with other anti-HIV agents. Clin Pharmacokinet 35 1998 275 291
4. J Cami R de la Torre J Ortuño Pharmacokinetics of ecstasy (MDMA) in healthy subjects Eur J Clin Pharmacol 52 suppl 1997 A168
5. Ortuño J, Pizarro N, Farré M, et al. Quantification of 3,4-methylenedioxymethamphetamine (MDMA) and its metabolites in plasma and urine by gas chromatography with nitrogen-phosphorous detection (GC/NPD). JChromatogr B (in press).